The evaluation of haemoglobin variants in the context of glycaemic control is increasingly recognised as a critical factor in optimising diabetes management. Variations in the structure of haemoglobin ...

ORLANDO, Fla.—Variant hemoglobin phenotypes, including sickle cell trait and hemoglobin C trait, may be associated with resistance to treatment with erythropoiesis-stimulating agents (ESAs) among ...

Trinity Biotech plc. received U.S. FDA 510(k) clearance for its lab-based hemoglobin diagnostic system, the Premier Resolution system, which the company hopes will allow it to regain its market ...

Scientists have found a potential new gene variant target to treat sickle cell disease, an inherited blood disorder that affects about 300,000 people globally each year, with limited treatment options ...